The different genetic alterations found in type I and type II endometrial cancers suggested that these subtypes may have distinct etiologies.36 Molecular genetic profile with type I showed defects in DNA‐mismatch repair and mutations in PTEN, K‐ras, and beta‐catenin. This evidence concerns the gene PTEN and endometrial cancer.